Modulating metastasis by a lymphangiogenic switch in prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Medical Imaging

Background:

• Prostate cancer metastasis is challenging to detect and treat in advanced stages.
• Tumor lymphangiogenesis, the formation of new lymphatic vessels, is implicated in cancer spread.
• Noninvasive molecular imaging can aid in assessing metastatic processes.

Purpose of the Study:

• To investigate the role of tumor lymphangiogenesis in prostate cancer metastasis.
• To compare the metastatic potentials of different human prostate cancer xenograft models.
• To evaluate the impact of vascular endothelial growth factor C (VEGF-C) on metastasis.

Main Methods:

• Utilized bioluminescence imaging with luciferase-labeled prostate cancer cells (LAPC-4, LAPC-9, PC3, CWR22Rv-1) in xenograft models.
• Monitored tumor implantation sites and the appearance of metastases over several months.
• Confirmed metastatic lesions via immunohistochemistry and characterized tumor angiogenic and lymphangiogenic profiles.
• Genetically engineered LAPC-9 cells to overexpress VEGF-C to assess its role in metastasis.

Main Results:

• Demonstrated varying metastatic potentials among cell lines: CWR22Rv-1 and PC3 > LAPC-4 > LAPC-9.
• Correlated higher metastatic potential with increased endogenous VEGF-C production and presence of tumor lymphatics.
• Showed that induced VEGF-C overexpression in LAPC-9 cells enhanced lymphangiogenesis and led to metastasis development.

Conclusions:

• Tumor lymphatics play a significant role in the metastatic process of human prostate cancer.
• VEGF-C is a key factor in promoting prostate cancer metastasis by driving lymphangiogenesis.
• Molecular imaging provides a valuable tool for detecting and quantifying micrometastases.